Imaging Drugs Make Jump To Devices In New Decision By FDA

  
Goldfish jumping from one bowl into another
Because user-fee deadlines for prescription and generic drugs are approaching, the agency says firms should pay those fees now and ask for a refund after the transition. • Source: Alamy

More from Review Pathways

More from Pathways & Standards